{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-061184","form_type":"8-K","ticker":"QNRX","cik":"0001671502","company_name":"Quoin Pharmaceuticals, Ltd.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.280443+00:00","generated_at":"2026-05-19T01:31:31.978667+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Quoin Pharmaceuticals sets 2025 AGM for August 21; shareholder proposal deadline June 30","bullets":["2025 Annual General Meeting scheduled for August 21, 2025.","Shareholder proposals under Rule 14a-8 must be received by June 30, 2025.","Notice for proxy solicitations for director nominees other than company's must be given by June 30, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-061184","json":"https://secwatch.observer/filing/0001104659-25-061184.json","markdown":"https://secwatch.observer/filing/0001104659-25-061184.md","text":"https://secwatch.observer/filing/0001104659-25-061184.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925061184/0001104659-25-061184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925061184/tm2518339d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T01:31:31.978667+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}